JPMorgan Upgrades Teva Pharma (TEVA) to Neutral
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $13.01 +1.01%
Rating Summary:
12 Buy, 25 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
12 Buy, 25 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
JPMorgan upgraded Teva Pharma (NYSE: TEVA) from Underweight to Neutral.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $47.96 yesterday.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $47.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roth/MKM Upgrades Albertsons Companies Inc. (ACI) to Buy, 'Fundamental Floor and Improved Deal Likelihood'
- Piper Sandler Upgrades BlackLine (BL) to Neutral
- CFRA Upgrades Taylor Wimpey Plc. (TW/:LN) (TWODF) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
